Table 1. Antimicrobial resistance pattern of MRSA phage types.
| 42E (n=25) | 42E/47/54/75 (n=8) | 42E /47 (n=3) | 47 (n=1) | Non- typable (n=11) | |
|---|---|---|---|---|---|
| D-test positive | 8 32% | 7 87.5% | 0 | 1 100% | 4 36.3% |
| Erythromycin | 17 68% | 7 87.5% | 2 66.6% | 1 100% | 6 54.4% |
| Ciprofloxacin | 20 80% | 6 75% | 2 66.6% | 1 100% | 10 90% |
| Tetracycline | 12 48% | 5 62.5% | 0 | 1 100% | 7 63.6% |
| Gentamicin | 18 72% | 8 100% | 1 33.3% | 0 | 7 63.6% |
| Amikacin | 8 32% | 2 25% | 1 33.3% | 0 | 3 27.2% |
| Netilmicin | 2 8% | 1 12.5% | 0 | 0 | 0 |
| Cotrimoxazole | 23 92% | 8 100% | 2 66.6% | 1 100% | 10 91% |
| Chloramphenicol | 1 4% | 6 75% | 0 | 0 | 0 |
| Vancomycin | 0 | 0 | 0 | 0 | 0 |
| Linezolid | 0 | 0 | 0 | 0 | 0 |
| Mupirocin | 0 | 0 | 0 | 0 | 0 |
| Rifampicin | 0 | 0 | 0 | 0 | 0 |